Proteus Syndrome
·MeSH: Proteus Syndrome
Prevalence
0.1 / 100K
3 drugs in development·3 companies·2 clinical trials
Drug Pipeline by Phase
Phase 2(2)
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| miransertib | ARQULE INC (ARQL) |
Compare drugs
Frequently asked questions
How many drugs are in development for Proteus Syndrome?
BioSniper tracks 3 drugs in development for Proteus Syndrome across 3 companies.
How many clinical trials target Proteus Syndrome?
There are 2 clinical trials targeting Proteus Syndrome tracked by BioSniper.
What is the prevalence of Proteus Syndrome?
The estimated prevalence of Proteus Syndrome is approximately 0.1 per 100,000 population.
Deep-dive into Proteus Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis